-
61
Two Patients with Therapy-Resistant Pemphigus Vulgaris and Severe Underlying Disease Showing Good Response to a New IVIg Preparation
Published 2025-01-01Subjects: Get full text
Article -
62
Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes
Published 2024-10-01Subjects: Get full text
Article -
63
-
64
The Role of Bronchoalveolar Lavage in Therapeutic Antimicrobial Choices for Hematologic Patients with Pulmonary Infiltrates
Published 2025-01-01Subjects: Get full text
Article -
65
Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
Published 2023-12-01Subjects: Get full text
Article -
66
Polarization of ILC2s in Peripheral Blood Might Contribute to Immunosuppressive Microenvironment in Patients with Gastric Cancer
Published 2014-01-01“…These results suggested that there are polarized ILC2s in gastric cancer patients which might contribute to immunosuppressive microenvironment and closely related to the upregulation of MDSCs and M2 macrophages.…”
Get full text
Article -
67
Listeria monocytogenes Meningitis in an Immunosuppressed Patient with Autoimmune Hepatitis and IgG4 Subclass Deficiency
Published 2015-01-01“…Her medical history included immunosuppressive treatment with prednisolone and azathioprine for autoimmune hepatitis. …”
Get full text
Article -
68
Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension
Published 2025-01-01Subjects: Get full text
Article -
69
Systemic Candida parapsilosis Infection Model in Immunosuppressed ICR Mice and Assessing the Antifungal Efficiency of Fluconazole
Published 2015-01-01“…This study was to establish a systemic C. parapsilosis infection model in immunosuppressed ICR mice induced by cyclophosphamide and evaluate the antifungal efficiency of fluconazole. …”
Get full text
Article -
70
Should My Patient with Inflammatory Bowel Disease on Immunosuppressive Therapy be Vaccinated against Influenza Virus?
Published 2010-01-01“…Crohn’s disease and ulcerative colitis are variants of inflammatory bowel disease (IBD) for which immunosuppressive therapy is often required. Immunosuppressed patients are at increased risk for infections, including vaccine-preventable diseases such as influenza. …”
Get full text
Article -
71
Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression
Published 2025-02-01Subjects: Get full text
Article -
72
Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis
Published 2025-01-01“…Objective To investigate the rate and factors influencing renal relapse (RR) in proliferative lupus nephritis (LN) patients who discontinued immunosuppressive therapy (IST), as well as the long-term renal outcomes following RR.Methods Retrospective, single-centre study of biopsy-confirmed LN patients who had received IST for at least 36 months and maintained complete renal response (CRR) for a minimum of 12 months before therapy discontinuation.Results Of a total of 106 patients meeting the inclusion criteria, 76 with proliferative classes were selected for analysis. …”
Get full text
Article -
73
A Rapid and Satisfactory Outcome with Combined Immunosuppressive Therapy in Acquired Haemophilia A with Underlying Tuberculosis
Published 2022-01-01“…He was treated with both antituberculous and combined-aggressive immunosuppressive therapy which resulted in satisfactory disease remission.…”
Get full text
Article -
74
Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche
Published 2025-02-01“…Finally, attenuating this immunosuppressive milieu by neutrophil depletion, neutrophil extracellular trap (NET) inhibition, or immune checkpoint therapy abrogates metastatic outgrowth. …”
Get full text
Article -
75
Biomimic Nanodrugs Overcome Tumor Immunosuppressive Microenvironment to Enhance Cuproptosis/Chemodynamic‐Induced Cancer Immunotherapy
Published 2025-02-01“…However, the tumor immunosuppressive microenvironment (TIM) attenuates the efficiency of the immune response. …”
Get full text
Article -
76
Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants
Published 2012-01-01“…Treatment significantly increased immunosuppressive IL-10/IL-4/TGF-β production and significantly decreased proinflammatory IFN-γ/TNF-α. …”
Get full text
Article -
77
Immunomodulatory Effects of Robinia pseudoacacia Polysaccharides on Live Vaccine against Infectious Bronchitis in Immunosuppressive Chickens
Published 2019-01-01“…In order to investigate the immunomodulatory effect of Robinia pseudoacacia Polysaccharides (RPPS) on vaccine against Infectious Bronchitis (IB) in immunosuppressive chickens, the artificial leukemia chicken model was established and then the IB live vaccine (H120 strain) was immunized. …”
Get full text
Article -
78
Disseminated Chickenpox Following Live Varicella Vaccination in a Crohn’s Disease Patient on Combination Immunosuppression
Published 2025-01-01“…We present a case of a patient with refractory Crohn’s disease (CD) who developed primary varicella (chickenpox) of a vaccine-viral strain after receiving combination immunosuppression with high-dose corticosteroids, tumor necrosis factor inhibitor (TNFi), and a Janus kinase inhibitor (JAKi) in the hospital. …”
Get full text
Article -
79
The Mechanisms of Systemic Inflammatory and Immunosuppressive Acute-on-Chronic Liver Failure and Application Prospect of Single-Cell Sequencing
Published 2022-01-01“…The late stage of ACLF is mainly characterized by immunosuppression. In this process, the dysfunction of monocyte and macrophage is reflected in the downregulation of HLA-DR and upregulation of MER tyrosine kinase (MERTK), which weakens the antigen presentation function and reduces the secretion of inflammatory cytokines. …”
Get full text
Article -
80
TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
Published 2025-02-01“…Elevated TUBA1B levels are associated with an immunosuppressive tumor microenvironment, impacting cancer progression and treatment outcomes. …”
Get full text
Article